Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation
- PMID: 2433405
- DOI: 10.1016/0022-510x(87)90209-7
Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation
Abstract
Phytanic acid accumulation has for more than 20 years been used as a diagnostic criterion of Refsum's disease. Recently, however, phytanic acid has also been found in peroxisomal disorders (Zellweger's syndrome, neonatal adrenoleukodystrophy, infantile Refsum's syndrome, rhizomelic chondrodysplasia punctata). The 17 patients with Refsum's disease in the present study had serum phytanic acid values differing from 73 to less than 0.5 mg/dl (normal). alpha-Oxidation of phytanic acid in skin fibroblast cultures showed a defective capacity in all, with only small differences in residual activity. Phytanic acid determinations in serum from 3 of the 7 patients with peroxisomal disorders showed slightly elevated levels in 2. The alpha-oxidation capacity in the fibroblasts was defective in all, with a residual activity similar to that of Refsum's disease. An assay of the alpha-oxidation capacity may be useful in the diagnosis of both Refsum's disease and the peroxisomal disorders. The distinction between Refsum's disease and the peroxisomal disorders can easily be done on a clinical basis.
Similar articles
-
Disorders related to the metabolism of phytanic acid.Scand J Clin Lab Invest Suppl. 1986;184:3-10. Scand J Clin Lab Invest Suppl. 1986. PMID: 2438746 Review.
-
Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.Scand J Clin Lab Invest. 1986 May;46(3):283-7. doi: 10.3109/00365518609083671. Scand J Clin Lab Invest. 1986. PMID: 2424078
-
Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: plasma changes and skin fibroblast phytanic acid oxidase.Hum Genet. 1985;70(2):172-7. doi: 10.1007/BF00273077. Hum Genet. 1985. PMID: 2408988
-
Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.Hum Genet. 1989 Jan;81(2):175-81. doi: 10.1007/BF00293897. Hum Genet. 1989. PMID: 2463966
-
[Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].Wien Klin Wochenschr. 1992;104(21):665-70. Wien Klin Wochenschr. 1992. PMID: 1282286 Review. German.
Cited by
-
Genetics behind Cerebral Disease with Ocular Comorbidity: Finding Parallels between the Brain and Eye Molecular Pathology.Int J Mol Sci. 2022 Aug 26;23(17):9707. doi: 10.3390/ijms23179707. Int J Mol Sci. 2022. PMID: 36077104 Free PMC article. Review.
-
Similar genomic proportions of copy number variation within gray wolves and modern dog breeds inferred from whole genome sequencing.BMC Genomics. 2017 Dec 19;18(1):977. doi: 10.1186/s12864-017-4318-x. BMC Genomics. 2017. PMID: 29258433 Free PMC article.
-
Cardiac Involvement in Movement Disorders.Mov Disord Clin Pract. 2021 Apr 7;8(5):651-668. doi: 10.1002/mdc3.13188. eCollection 2021 Jul. Mov Disord Clin Pract. 2021. PMID: 34307738 Free PMC article. Review.
-
Thiamine deficiency in pregnancy and lactation: implications and present perspectives.Front Nutr. 2023 Apr 20;10:1080611. doi: 10.3389/fnut.2023.1080611. eCollection 2023. Front Nutr. 2023. PMID: 37153911 Free PMC article. Review.
-
Eye involvement in inherited metabolic disorders.Ther Adv Ophthalmol. 2020 Dec 29;12:2515841420979109. doi: 10.1177/2515841420979109. eCollection 2020 Jan-Dec. Ther Adv Ophthalmol. 2020. PMID: 33447730 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources